Recurrent Head And Neck Cancer Squamous Cell Carcinoma Global Clinical Trials Review, H1, 2014
GlobalData's clinical trial...
clinical Trial Overview Of Pfizer Inc. 44
amgen Inc. 45
clinical Trial Overview Of Amgen Inc. 45
glaxosmithkline Plc 46
cl...
Upcoming SlideShare
Loading in …5
×

Recurrent head and neck cancer squamous cell carcinoma global clinical trials review, h1, 2014

256 views

Published on

The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Recurrent Head And Neck Cancer Squamous Cell Carcinoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Published in: Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
256
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Recurrent head and neck cancer squamous cell carcinoma global clinical trials review, h1, 2014

  1. 1. Recurrent Head And Neck Cancer Squamous Cell Carcinoma Global Clinical Trials Review, H1, 2014 GlobalData's clinical trial report, Recurrent Head And Neck Cancer Squamous Cell Carcinoma Global Clinical Trials Review, H1, 2014" provides data on the Recurrent Head And Neck Cancer Squamous Cell Carcinoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Recurrent Head And Neck Cancer Squamous Cell Carcinoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Recurrent Head And Neck Cancer Squamous Cell Carcinoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type Listings of discontinued trials (suspended, withdrawn and terminated) Reasons to buy Understand the dynamics of a particular indication in a condensed manner Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies table Of Contents table Of Contents 2 list Of Tables 4 list Of Figures 6 introduction 7 recurrent Head And Neck Cancer Squamous Cell Carcinoma 7 report Guidance 7 clinical Trials By Region 8 clinical Trials And Average Enrollment By Country 9 top Five Countries Contributing To Clinical Trials In Asia-pacific 11 top Five Countries Contributing To Clinical Trials In Europe 12 top Countries Contributing To Clinical Trials In North America 13 top Countries Contributing To Clinical Trials In Middle East And Africa 14 top Five Countries Contributing To Clinical Trials In Central And South America 15 clinical Trials By G7 Countries: Proportion Of Recurrent Head And Neck Cancer Squamous Cell Carcinoma To Oncology Clinical Trials 16 clinical Trials By Phase In G7 Countries 17 clinical Trials In G7 Countries By Trial Status 18 clinical Trials By E7 Countries: Proportion Of Recurrent Head And Neck Cancer Squamous Cell Carcinoma To Oncology Clinical Trials 19 clinical Trials By Phase In E7 Countries 20 clinical Trials In E7 Countries By Trial Status 21 clinical Trials By Phase 22 in Progress Trials By Phase 23 clinical Trials By Trial Status 24 clinical Trials By End Point Status 25 unaccomplished Trials Of Recurrent Head And Neck Cancer Squamous Cell Carcinoma 26 subjects Recruited Over A Period Of Time 31 clinical Trials By Sponsor Type 32 prominent Sponsors 33 top Companies Participating In Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics Clinical Trials 34 prominent Drugs 36 clinical Trial Profiles 37 clinical Trial Overview Of Top Companies 37 sanofi 37 clinical Trial Overview Of Sanofi 37 e. Merck Kg 38 clinical Trial Overview Of E. Merck Kg 38 novartis Ag 40 clinical Trial Overview Of Novartis Ag 40 eli Lilly And Company 41 clinical Trial Overview Of Eli Lilly And Company 41 astrazeneca Plc 42 clinical Trial Overview Of Astrazeneca Plc 42 f. Hoffmann-la Roche Ltd. 43 clinical Trial Overview Of F. Hoffmann-la Roche Ltd. 43 pfizer Inc. 44 Recurrent Head And Neck Cancer Squamous Cell Carcinoma Global Clinical Trials Review, H1, 2014
  2. 2. clinical Trial Overview Of Pfizer Inc. 44 amgen Inc. 45 clinical Trial Overview Of Amgen Inc. 45 glaxosmithkline Plc 46 clinical Trial Overview Of Glaxosmithkline Plc 46 c. H. Boehringer Sohn Ag & Co. Kg 47 clinical Trial Overview Of C. H. Boehringer Sohn Ag & Co. Kg 47 clinical Trial Overview Of Top Institutes / Government 48 national Cancer Institute 48 clinical Trial Overview Of National Cancer Institute 48 the University Of Texas M. D. Anderson Cancer Center 53 clinical Trial Overview Of The University Of Texas M. D. Anderson Cancer Center 53 european Organization For Research And Treatment Of Cancer 54 clinical Trial Overview Of European Organization For Research And Treatment Of Cancer 54 the University Of Chicago 55 clinical Trial Overview Of The University Of Chicago 55 memorial Sloan Kettering Cancer Center 56 clinical Trial Overview Of Memorial Sloan Kettering Cancer Center 56 university Of Pittsburgh 57 clinical Trial Overview Of University Of Pittsburgh 57 southwest Oncology Group 58 clinical Trial Overview Of Southwest Oncology Group 58 roswell Park Cancer Institute 59 clinical Trial Overview Of Roswell Park Cancer Institute 59 sidney Kimmel Comprehensive Cancer Center 60 clinical Trial Overview Of Sidney Kimmel Comprehensive Cancer Center 60 eastern Cooperative Oncology Group 61 clinical Trial Overview Of Eastern Cooperative Oncology Group 61 five Key Clinical Profiles 62 appendix 173 abbreviations 173 definitions 173 research Methodology 174 secondary Research 174 about Globaldata 175 contact Us 175 disclaimer 175 source 176 ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price. Contact: M/s Sheela, 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-997-4948 Email: sales@researchmoz.us Website: http://www.researchmoz.us/ Recurrent Head And Neck Cancer Squamous Cell Carcinoma Global Clinical Trials Review, H1, 2014

×